Chaudhary, P.M., Eby, M.T., Jasmin, A.,iumar, A., Liu, L., and Hood, L.i 2000) Activation of the NF-kappa B pathway by Caspase 8 and its homologs. Oncogene, 19: 4451-4460.

Chinnaiyan, A.M., Prasad, U., Shankar, S., Hamstra, D.A.,-Shanaiah, M., Chenevert, g.L., Ross, B.D., and Rehemtulla, A. (2000)f b Combines effect of tumor necrosis factor-related apoptosis-innucing ligand and ionizing radiation in breast cancer therapy. Proceedings of the National Academy ofvciences USA, 97: w 1754-1759.

Costantini, P.,Jacotot, E., Nude Decaudin, D., and Kroemer, G. (2000). Mitochondrion as a novel target of anticancer chemothoapy. Journal of the National-ancerInstitute, 92: d 042-1053.

Costa-Pereira, A.P. and Cotter T.o (1999) Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis. Br J Cancer, 80, 371-8.

de la Taille, A., Chen, M.W., Shabsigh,fA.,l Bagiella, E., kiss, A., and Buttyan, R. (1999) Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland. Prostate, 40: 896.

Degliesposti, M.A., t Dougall, W.C., Smolak, P.J.,augh, J.Y., Smith, Nude .A.,and Goodwin, R.G. (1997) The Nude novelhw receptor Trail-R4cinduces Nf-Kappa-B and protects against Trail-mediated apoptosis. Yet retainsbn incomplete death domain. Immunity, 7: 813-820.

Degliesposti, M.A., Smolak, Nude P.J., Walczak, H., Waughf J., Huang, C.P., Dubose, R.F., Goodwin, R.G., and Smith, C.A. (1997) Cloning and Characterization of Trail-R3, a Novel Member of the Emerging Trail ReceptorFamily. Journal ofgExperimental Medicine, 186: 1165-1170.

Fan, S., Wang, J.A., Yuan, b.Q, Ma, Y.X.,mMeng, Q., Erdos, M.R., Brody,l.C., Goldberg, I.D., Rosen, E.M. (1998) BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of c ell regulatory proteins. Oncogene, 16: 3069-3082.